I. Introduction
The increasing availability and adoption of electronic medical records (EMRs) of various forms has generated substantial optimism concerning possible consequent improvements in productivity, costs, and quality within the health-care sector (e.g., Hillestad et al. 2005) . This optimism has proven substantial enough to even spur the passage of the Health Information Technology for Economic and Clinical Health (HITECH) Act in 2009, which includes large financial incentives for adoption. In contrast, the extant literature measuring various impacts of EMR adoption provides little indication of dramatic returns (e.g., Agha 2014; McCullough et al. 2010; McCullough, Parente, and Town 2013; Parente and McCullough 2009 ). However, the scope of these analyses, particularly with regard to health outcomes, has largely been limited because of data constraints. In particular, previous studies have focused on mortality among Medicare patients as the primary health Seth Freedman (corresponding author, freedmas@indiana.edu), School of Public and Environmental Affairs, Indiana University. Haizhen Lin and Jeffrey Prince, Kelley School of Business, Indiana University. outcome, and large-scale studies generally have focused only on the Medicare population. The lone large-scale study that we are aware of using data from non-Medicare patients is Miller and Tucker (2011) , who find that the availability of EMRs within a county decreases infant mortality rates.
In this study, we build and utilize a newly integrated data set to analyze the effect of EMR adoption on health outcomes for a broader patient population, and for less severe, more common adverse health outcomes known as patient safety indicators (PSIs). To our knowledge, our study is the first that combines data on EMR adoption with a nationally representative sample of hospital discharges of patients of all ages. In addition, the use of PSIs is also novel as it enables us to capture quality improvement along dimensions other than those measured by patient mortality. Particularly, we examine whether EMR adoption impacts PSIs for the general population, and whether the size of the impact varies according to a patient's level of "complexity, " measured in several different ways. Further, by examining multiple health outcomes (i.e., PSIs, inpatient mortality, and length of stay) and different types of EMRs, and accounting for differing levels of patient complexity, we are able to learn more about potential mechanisms through which EMRs impact health outcomes.
Expanding the population and type of health outcome for which we have an empirical assessment of EMRs' effectiveness, along with an improved understanding of the mechanisms by which they operate, can have a significant impact on public policy and subsequent EMR research. It can have a powerful impact on how the US government should be setting policy as pertains to EMR. In particular, it will help to better assess the potential social value of incentive programs and whether targeted incentives may be warranted. Further, it can help inform hospitals' adoption decisions and potentially patients' choice of hospitals.
Our empirical analysis focuses on two EMR applications, Computerized Physician Order Entry (CPOE) and Physician Documentation (PD), which have experienced significant increases in adoption during our study period and are the focus of recent policies incentivizing EMR adoption. We find that CPOE substantially decreases the occurrence of preventable adverse events as measured by PSIs for simple cases. For example, CPOE is associated with an 11 percent drop in the probability of experiencing at least one postoperative adverse event for cases with no more than one comorbidity. We find consistent results for simple cases defined in alternative ways. Given that CPOE is more amenable to decision support (which we discuss in Section II.C), our finding is suggestive of decision support playing an important role in EMR effectiveness. This finding also stands in contrast to previous results focusing on mortality as an outcome and suggests that EMRs indeed have important effects on patient outcomes less severe than mortality.
Our findings suggest interesting implications about the effectiveness of EMRs in improving health outcomes and provide an important new set of findings to complement the growing literature on the effect of EMRs on health outcomes. First, our findings suggest that EMRs play a role in improving patient well-being by decreasing preventable adverse events among the nonsenior population. A significant group of previous studies has focused largely on the senior population and has lacked strong evidence of quality improvement.
1 For example, Agha (2014) finds little effect of EMR adoption on patient mortality, medical complication rates, adverse drug events, and readmission rates. McCullough et al. (2010) find some evidence of improvement in quality measures, but temper this finding by concluding that achieving substantive benefits from EMR adoption at a national level may be a lengthy process. Parente and McCullough (2009) find some improvement in patient safety due to EMR adoption, but conclude there is not enough evidence to draw a strong link between EMR and improvements in patient safety for the Medicare population.
2 Different from these studies, our paper examines health effects for a broadly defined, nationally representative population. In addition, we focus on patient safety, which is arguably a more relevant measure for the nonsenior population and can shed light on the impacts of EMRs on important, but nondeadly, adverse health events.
Second, our results highlight the importance of exploring heterogeneity among population subgroups, especially when considering different functionalities associated with different EMR applications. Our finding that less complex cases are predominantly benefiting from EMR technologies may seem surprising; however, the details of the technologies, the outcome we are studying, and the population for whom we find an effect suggests a plausible mechanism for this finding-improvement via decision support. Our finding also complements previous findings of McCullough, Parente, and Town (2013) , who explore heterogeneity for four high-frequency and high-severity diagnoses within the Medicare population. They find that EMRs reduce mortality for the highest-severity Medicare patients, particularly those with diagnoses that require information management and care coordination. Our inclusion of a younger, less complex patient population and focus on outcomes less severe than mortality (and potentially more relevant to a less complex patient population) affords us additional opportunity to empirically assess channels through which EMRs improve patient care. Taken together these studies suggest that advanced EMRs can be beneficial beyond basic patient data collection.
Third, our paper is also related to the existing studies on the effect of EMRs on cost of care. Despite some relatively sanguine findings concerning costs (e.g., Wang et al. 2003; Hillestad et al. 2005) , the majority of the literature suggests cost savings have been small or nonexistent (see Sidorov (2006) for a literature review and Agha (2014) for a more recent study). It is noteworthy that Dranove et al. (2014) find that EMRs, on average, generate a slight increase in operational costs. However, this average effect is a combination of cost reductions for hospitals in "favorable" locations (i.e., due to IT complementarities) and large cost increases for hospitals in "unfavorable" locations. As discussed below, patient safety indicators have been linked to longer hospital stays and higher hospital charges (Zhan and Miller 2003) . Therefore, our results also have implications for EMRs' role in reducing the cost of care by limiting adverse events with additional downstream costs.
1 Other studies on health outcomes have included the nonsenior population and found more positive findings, but have utilized small, focused sets of data, primarily within a single hospital setting (e.g., Bates et al. 1998; Bates et al. 1999; Simeonova and Koulayev 2013) . 2 Their study was limited to a sample of Medicare patients during 1999 and 2002. They also study a different set of EMRs such as nurse charts and picture archiving and communications systems.
Our paper lastly contributes to the broader literature on the effect of information technology (IT). In the health-care setting, Athey and Stern (2002) find IT linking 911 caller identification to a location database speeds emergency response and reduces short-term mortality and hospital costs. Javitt, Rebitzer, and Reisman (2008) examine a randomized implementation of decision support tools within an HMO (health maintenance organization) population and find that these tools reduce costs and improve quality. IT has also been studied in other settings such as banking (Autor, Levy, and Murnane 2002) and trucking (Baker and Hubbard 2003; Hubbard 2003) . Particularly, Autor, Levy, and Murnane (2003) find that IT substitutes for labor in routine tasks and complements labor in nonroutine tasks that involve problem-solving and complex communication. The totality of our findings suggests that at least some EMRs improve health outcomes through clinical decision support, a mechanism consistent with complementarities between IT and skilled labor inputs. Our findings also have potentially broader implications in light of recent work distinguishing communication technologies from information technologies (Bloom et al. 2014) . Specifically, it is natural to view EMRs facilitating care coordination as communication technologies, and EMRs facilitating decision support as information technologies. Bloom et al. (2014) find that the former technologies work toward firm centralization while the latter work toward firm decentralization. To the extent that this insight applies to hospitals, our findings suggest that the EMRs tending toward decentralization (CPOE) have proven particularly effective, at least for some health outcomes.
II. Electronic Medical Records and Health Outcomes
In this section, we describe the EMR technologies that we study, the measures of patient safety that we utilize as outcomes, and potential links between EMRs and these outcomes.
A. E M R T E C H N O LO G I E S
As noted in Dranove et al. (2014, 244) , an electronic medical record is a "catchall expression used to characterize a wide range of technologies used by hospitals to keep track of utilization, costs, outcomes, and billings. " EMR technologies have varying levels of complexity. Basic EMR applications can be used to store, organize, and retrieve patients' information, and generally include Enterprise EMR, Clinical Data Repository (CDR), and Order Entry. More advanced EMR applications present medical history, recommend drugs, and help health-care providers make diagnosis and treatment decisions (Wang 2012; Agha 2014) . This group includes applications such as Clinical Decision Support System (CDSS), Computerized Practitioner Order Entry (CPOE), and Physician Documentation (PD).
3 These advanced technologies require more complex implementation and require physicians to learn to interact with them directly (Dranove et al. 2014; Dranove et al. 2015) .
We focus our analysis on two advanced technologies: CPOE and PD. CPOE systems allow providers to directly enter medical orders into a computer system. Most CPOE systems allow physicians to specify medication orders as well as laboratory, admission, radiology, referral, and procedure orders (Dixon and Zafar 2009) . CPOE is typically used in conjunction with an electronic health record while the treating physician is creating a treatment plan for the patient. Additionally, rules-based protocols, automatic reminders, checklists, and error-checking functions are often built into CPOE systems to improve adherence to guidelines and compliance with protocols (Sittig and Stead 1994; McCullough, Parente, and Town 2013) . PD provides a structured template for physicians to create clinical documentation of a patient's condition and treatment. PD also generates diagnostic codes from clinical information; these codes are typically used for billing purposes.
We focus on these two advanced technologies for two main reasons. 4 First, as detailed in Section III, diffusion of these two advanced technologies is more relevant to our study period, which covers more recent years than many previous studies. Second, recent policy incentivizing EMR adoption and utilization requires providers to demonstrate advanced capabilities above and beyond digitization of patient data. For example, CPOE implementation is a major requirement for Meaningful Use eligibility under the HITECH Act. Stage 1 Meaningful Use criteria specifies that 30 percent of patients must have their medication orders entered via CPOE, and Stage 2 requires 60 percent of medications, 30 percent of laboratory, and 30 percent of radiology orders to occur via CPOE. In their study of the effect of the HITECH Act on EMR adoption, Dranove et al. (2015) examine adoption of these two technologies as their primary outcome. As advanced technologies are intended to enable health-care providers to take better advantage of electronic patient data that are stored in basic technologies, it is important to examine whether these more advanced applications, such as CPOE and PD, have produced their intended benefits of improving patient outcomes.
B. PAT I E N T S A F E T Y I N D I C AT O R S
Developed by the Agency for Healthcare Research and Quality (AHRQ), patient safety indicators (PSIs) measure preventable in-hospital complications and adverse events. These indicators are well-defined and have gained traction as a health outcome of interest in the general literature on policy interventions and hospital quality of care (e.g., Iizuka 2013) .
PSIs comprise a particularly important set of outcomes for the purpose of identifying the effect of EMR adoption, and using these measures of patient outcomes is one important innovation of our study. PSIs have the advantage of being more variable than other health outcome measures such as mortality, and allow us to examine the effects of EMRs on meaningful health outcomes that are less severe than mortality. Patient mortality has been commonly used as a reliable indicator for quality of care, especially for the elderly and severely sick population. However, being an extreme outcome measure, patient mortality might fail to capture improvement in health outcomes resulting from EMR adoption if EMRs have impacts on less severely ill populations.
In addition to representing a significant indicator of patient well-being, PSIs are linked to increased health-care utilization and cost. Zhan and Miller (2003) use the 2000 Nationwide Inpatient Sample to examine how adverse events measured by patient safety indicators impact health-care utilization and eventual mortality. They use a multivariable matching estimator to compare length of stay, hospital charges, and in-hospital mortality for patients experiencing an adverse event to observably similar patients within the same hospital not experiencing an adverse event. They find statistically significant differences in these three outcomes for all of the PSIs that we examine in this paper. For example, they find that patients with postoperative pulmonary embolism or deep vein thrombosis spend 5.36 additional days in the hospital, have higher hospital charges by $21,709, and have a 6.56 percent higher in-hospital mortality rate. While these differences may be partially driven by unobserved severity, they argue that PSIs have important implications for downstream health-care utilization and costs, and in addition to representing decreased patient well-being, can lead to potential increases in mortality.
AHRQ identifies a set of 15 PSIs (excluding birth and obstetric trauma related PSIs), which it labels PSI 2 through PSI 16. We select our analysis PSIs through the following steps. We first exclude four PSIs with extremely low incidence rates among the potentially affected populations (PSIs 2, 3, 5, and 16) and three PSIs with very small relevant populations at risk (PSIs 4, 13, and 14) . We then separate the remaining PSIs into those potentially impacted and those unlikely to be impacted by EMR availability. We make these decisions based on the opinion of clinical experts, following the strategy of Parente and McCullough (2009) . 5 PSIs with the potential to be impacted by EMR adoption include those that measure adverse events that can be prevented by checklists and reminders, by appropriate provision of medications or physical activity, and/or by the provision of detailed patient clinical information. We distinguish PSIs unlikely to be impacted by EMR as those predominantly determined by surgical skills and physical accidents. We present results of these PSIs as a falsification test of our main results. In this process we also drop the PSI related to central venous catheter-related bloodstream infection (PSI 7), because it is ambiguous whether it should be considered a "treatment" PSI or a "placebo" PSI. While it is largely determined by surgical techniques, decision support could also help to reduce its occurrence through reminding care givers to administer antibiotics to patients at risk.
Our main analysis focuses on four PSIs with the potential to be impacted by EMR adoption: postoperative hemorrhage or hematoma (PSI 9), postoperative physiologic and metabolic derangement rate (PSI 10), postoperative respiratory failure rate (PSI 11), and postoperative pulmonary embolism or deep vein thrombosis (PSI 12). In presenting our main results, we aggregate these into a single measure of those experiencing at least one of these four postoperative adverse events. The results for each individual PSI can be found in the Online Appendix (Appendix Table 3 ; see http://www.mitpressjournals.org/doi /suppl/10.1162/ajhe_a_00093). We use three additional PSIs in our falsification test: iatrogenic pneumothorax (PSI 6), postoperative hip fracture (PSI 8), and accidental puncture or laceration (PSI 15). Online Appendix Table 1 provides definitions of all of the PSI outcomes used in our analysis.
In this section we discuss the potential links between patient outcomes and our two technologies of interest: CPOE and PD. The core function of CPOE is to ensure standardized, legible, complete medical orders by only accepting typed orders in a standard and complete format. These systems also change the typical workflow by having the physician directly input the electronic orders rather than first conveying orders to a nurse or other medical staff. Because CPOE requires physicians to directly input orders electronically, they may be effective at reducing miscommunication and errors (McCullough, Parente, and Town 2013) that would lead to the occurrence of otherwise preventable adverse events. In addition, almost all CPOE systems include or interface with clinical decision support systems of varying sophistication (Kaushal and Bates 2001) . Therefore, CPOE systems typically also provide access to patient data, real-time feedback regarding the appropriateness of certain orders, formulation of diagnostics or therapy protocols, and clinical guideline adherence (Sittig and Stead 1994) . These rules-based protocols, automatic reminders, checklists, and error-checking functions may be expected to have direct impacts on preventable adverse events that patient safety indicators are intended to measure. For example, decision support may prompt physicians to order anticoagulants in order to prevent deep vein thrombosis (measured in PSI 12) among surgical patients, or it may better track IVs used to prevent electrolyte and fluid imbalance that could lead to physiological and metabolic derangement (PSI 10).
The core function of PD is to allow the physician to electronically document a patient's conditions and treatments in a systematic, structured manner. PD therefore has the potential to improve patient outcome through better document accessibility, increased legibility, and enhanced communication between practitioners through standard coding (Dranove et al. 2014) . Medical care often involves physicians processing a large amount of information/data, and this process becomes challenging if decisions require the coordination of multiple specialists. PD can support more effective communication and coordination that is not feasible with paper-based information management. Therefore, PD might be expected to particularly reduce adverse events when care is administered by multiple practitioners who must communicate efficiently and coordinate a patient's care.
To sum up, we present multiple channels through which CPOE and PD could reduce preventable adverse events in hospitals. Both applications can improve accuracy in communication that could lead to fewer errors. However, there are additional contrasting functions that these systems could provide. CPOE provides a platform by which the physician directly interacts with the IT system to submit orders and make treatment plans often in the context of embedded decision support tools to provide guidance or error checking (Chaudhry et al. 2006) . In contrast, PD enables physicians to clearly document and communicate patient information, so its functionality is likely more closely tied to communication and care coordination between multiple providers.
III. Data

A. D ATA C O N S T R U C T I O N
The data we use come from several sources, and to our knowledge, this is the first study using such integrated data. Our first source of data is the Healthcare Information and Management Systems Society (HIMSS) Analytics Database. HIMSS conducts an annual survey of health-care providers, including over 3,000 hospitals nationwide with more than 100 beds. The survey collects a wide range of information on more than 100 different health information technology applications, including CPOE and PD. For each of these applications we construct variables for whether a hospital has installed a system in a given year. 6 The HIMSS data we have span the years from 2003 to 2010. Our second data source is the Nationwide Inpatient Sample (NIS), collected by the AHRQ's Healthcare Cost and Utilization Project (HCUP). The NIS is a 20 percent, nationally representative, stratified sample of US community hospitals. Since NIS includes the universe of inpatient discharge records from these sampled hospitals, we are able to observe both Medicare and non-Medicare insured patients. For each discharge record, the data set includes information such as diagnosis and procedure codes, admission and discharge status, patient demographics, expected source of payment, length of stay, and hospital charges. The NIS also reports basic hospital characteristics including size, location, ownership type, and number of total discharges. NIS provides detailed patient data to build measures of PSIs, our main outcomes of interest. We calculate these indicators using a module provided by AHRQ. This module uses information in the discharge record, such as age, diagnosis-related groups, diagnosis codes, and procedure codes to identify the subpopulation of patients for whom a particular adverse event is relevant and those who have experienced the adverse event. For example, for the PSI indicating postoperative hemorrhage or hematoma, the module first identifies patients who have received operations and might be at potential risk, and then it determines which of these patients have experienced a hemorrhage or hematoma. When analyzing a particular PSI, our sample includes all patients at risk for the particular PSI. When analyzing our aggregate PSI, our sample includes all patients at risk for any of the four component PSIs.
We supplement the HIMSS and NIS data with American Hospital Associate (AHA) data. The AHA data are used to build a crosswalk between the HIMSS and NIS data. The only external hospital identifier in the HIMSS data is the hospital's Medicare provider numbers. The only external hospital identifier in the NIS data is the hospital's AHA ID number. AHA data contain both identification numbers, thus allowing us to merge the HIMSS and NIS data at the hospital-year level.
Ultimately, our merged sample includes more than 9.1 million patient observations at risk for any of the four EMR-sensitive PSIs from a total of 1,896 unique hospitals in 29 states.
7 Online Appendix Table 2 provides a comparison of our sample to the universe of hospitals from these 29 states and from all states. Overall our sample is slightly weighted toward nonprofit, large, teaching hospitals in urban areas, partly due to the NIS sampling design and the availability of the AHA ID number, but it provides a general representation of US hospitals.
While the NIS is not a panel of hospitals, a large fraction of hospitals appear in the data in multiple years. In our final sample spanning from 2003 to 2010, we observe 1,133 unique hospitals that appear at least twice.
8 This allows us to relate changes in patient safety to changes in EMR adoption within hospitals and over time. Others have used the fact that hospitals appear in the NIS in multiple years to exploit within-hospital changes in other contexts (e.g., Kolstad and Kowalski 2012) .
B. C O N S T R U C T I O N O F K E Y VA R I A B L E S
Our main analysis focuses on an aggregate PSI that equals one if a patient experiences any of the four postoperative adverse events expected to be linked to EMRs (PSI 9, PSI 10, PSI 11, and PSI 12). We are interested in exploring whether EMR adoption has heterogeneous effects based on patients' levels of complexity. To this end, we use a variety of proxies to measure various metrics of complexity, including number of comorbidities, diagnosis commonality, mortality risk, and functional severity. Regarding comorbidities, we define a less complex patient as one having no more than one comorbidity. To measure diagnosis commonality, we utilize diagnosis-related group (DRG) information. We consider a patient with a DRG code among the top 20 most frequent DRGs to be more common. To measure risk and severity, we use data available in the NIS severity files that differentiate patients by their mortality risk and their loss of function.
9 Regarding risk type, we define low-mortality-risk cases as those with a "minor likelihood of dying" and high-risk cases as those with "moderate, " "major, " or "extreme likelihood of dying. " Regarding severity, we define low-severity cases as those with "minor loss of function" and high-severity cases as those with "moderate, " "major, " or "extreme loss of function. " 7 Note that AHA identification numbers are only available for hospitals from a subset of states in the NIS, as some states have not authorized HCUP to release information that would specifically identify hospitals. We observe 3,858 unique hospitals in the 2003 to 2010 NIS data. Of these, 2,377 unique hospitals have AHA identification numbers available in the data. We are able to merge 1,922 of these hospitals to the HIMSS data. 8 The sample size for each regression described below varies, as the number of patients at potential risk for each PSI may differ. 9 The two variable names used are APRDRG_Risk_Mortality and APRDRG_Severity. They are assigned using software developed by 3M Health Information Systems. Their calculation includes the base APR-DRG, the severity of illness subclass, and the risk of mortality subclass within each base APR-DRG. See https://www.hcup-us.ahrq.gov/db/nation/nis/APR-DRGsV20MethodologyOverviewandBibliography.pdf.
F I G U R E 1 . EMR adoption by year
Notes: This figure reports the fraction of hospitals with CPOE and PD installed by year. The sample in this figure includes all hospitals for which we have at least two observations in the merged HIMSS and NIS data.
We also consider patient age, which can serve as a proxy for complexity along all four of the above categories. This is because we expect that the nonelderly, on average, present simpler, more common, less risky, and less severe cases. An additional advantage of exploring heterogeneity by age is that our results can be directly compared with existing studies that have focused on the elderly population alone through their focus on Medicare data. Figure 1 shows the fraction of hospitals in our analysis sample that have adopted CPOE and PD by year. CPOE adoption rates grew from 7 percent to 31 percent from 2003 to 2010. PD grew from 18 percent to 39 percent from 2005 to 2010. 10 This rapid diffusion provides the key variation we use to identify the effect of EMR adoption on patient safety. Table 1 displays sample means of hospital and patient characteristics. 11 In order to understand baseline differences in hospitals that do and do not adopt EMR technologies, we also show sample means for patients in adopting and nonadopting hospitals. Nonadopting hospitals are those that do not operate an EMR system during any of our sample period. Adopters are hospitals that at some point during our sample period adopt EMRs, and for Notes: This table presents sample means of hospital and patient characteristics, weighted by NIS discharge weights, with the unit of observation at the patient level. Nonadopters include patients in hospitals that have not adopted the respective EMR by the end of our sample period (2010). Adopters include patients in hospitals that adopt the respective EMR at some point during the study period, but include only patients from years prior to adoption. Sample means are adjusted for differential composition of years across subsamples by regressing each variable on year binary variables, and reporting the summation of the residual and sample mean for each variable. The number of observations across columns does not sum to 9.10 million because post-adoption years are excluded. Columns 4 and 5 also include only observations beginning in 2005.
C. S U M M A R Y S TAT I S T I C S
these hospitals we include only observations in pre-adoption years. 12 Adopting hospitals are more likely to be nonprofit, larger, teaching, and urban. Patients from adopting hospitals are more likely to be privately insured and white. There do not appear to be large differences in health-related characteristics between adopters and nonadopters; however, PSI rates are higher in adopting hospitals. These summary statistics show that there are some level differences between adopting and nonadopting hospitals, which will be absorbed by hospital fixed effects in our regressions. We also present a variety of tests to confirm that adopting and nonadopting hospitals do not have differential pre-trends or changes in patient characteristics. Table 2 , panel a, presents summary statistics of our PSI measures. For each PSI used in our analysis, a value of one indicates a patient experiencing an adverse event. Note that sample size varies across PSIs because the set of patients that are potentially at risk of each adverse event is different. We present the mean value of each PSI, which indicates the average rate of occurrence among its relevant population. For example, for the aggregate PSI, we observe an average of 1.81 percent with a standard deviation of 13.31 percent. In our sample, with a total of 9.1 million patients at potential risk, it suggests that about 165,000 patients had experienced at least one of the adverse events. Table 2 , panel b, provides summary statistics of the aggregate PSI by patient complexity. Not surprisingly, we find that the rate of occurrence of adverse events is lower for less complex patients; however, PSIs are still meaningful health outcomes for less complex patients as defined by most of our proxies. For example, nonelderly patients have a mean of 1.49 percent while elderly patients have a mean of 2.21 percent. Similarly, the mean is 0.53 percent for low-mortality-risk patients but as high as 4.02 percent for high-mortality-risk patients. We also explore how our measures of complexity overlap with each other. We find that among the 10 correlation coefficients between these measures, eight are smaller than 0.25. The remaining two are 0.36 (between low mortality and common DRG) and 0.49 (between low mortality and low severity). These numbers suggest that our measures for case complexity seem to provide meaningful variation along different dimensions.
IV. Empirical Model
Our general empirical strategy for testing the impact of EMR adoption is to relate withinhospital changes in patient safety over time to within-hospital changes in the availability of EMRs. Hospitals that do and do not have EMRs may be very different from each other. Therefore, it is important to exploit over time variation in EMR adoption. The key identifying assumption is that trends in the prevalence of PSIs are not correlated with unobserved adoption trends. In other words, our empirical strategy hinges on the idea that when a hospital adopts EMRs there are no concurrent events left unaddressed by our controls that would have an impact on patient safety. If this assumption is satisfied, we can attribute changes in patient safety to EMR adoption. (2013) and Agha (2014) provide extensive evidence that EMR adoption is unlikely to be correlated with preexisting trends in patient outcomes or severity in the Medicare context. In results shown below, we perform a variety of tests to ensure this assumption is likely to hold in our empirical context as well.
Our baseline empirical specification follows a linear probability model, with hospital and time fixed effects:
PSI iht represents the occurrence of an adverse event for patient i in hospital h during year t. α h is a set of hospital fixed effects, δ t is a set of year fixed effects, and Z iht stands for a set of patient-level control variables, including age, age squared, gender, race binary variables, payment binary variables, risk binary variables, severity binary variables, and 27 different comorbidity binary variables as defined by AHRQ.
13 EMR ht is a dummy variable for the presence of an EMR system installed in hospital h at year t. 14 We run five versions of the above model, each containing interactions with a different dimension of patient heterogeneity. Specifically, we define Simple iht as one of the following binary variables to represent patient heterogeneity: nonelderly, few comorbidities, common DRG, low-mortality risk, and nonsevere case. We then interact each dummy variable (Simple iht ) with the EMR ht dummy to allow the effect of EMR to differ on the basis of patient type. We also include group-specific year fixed effects (Simple iht × I_year) to allow outcomes to differ arbitrarily between each group over time, and interactions of the simple case dummy with a dummy for hospitals that never adopt EMR (Simple iht × NeverEMR h ) and with a dummy for hospitals that have adopted EMR prior to our study period (Simple iht × EarlyEMR h ). These two sets of hospitals both act as control groups, since they do not experience variation in EMR status during our study period. While hospital fixed effects absorb the main effects of these dummy variables, we allow PSIs to vary across case type and hospital type. 15 We are particularly interested in the estimates of β 2 , which measures the overall effect of EMR adoption, and β 3 , which measures whether the effect varies by patient complexity level. In addition, β 4 measures whether patient safety indicators vary based on patient complexity level itself. The estimation of the model uses discharge weighting, and standard 13 All of our results hold if we include some hospital-level controls such as hospital bed size, urban versus rural location, and ownership type. 14 Adding additional controls such as state-year fixed effects and differential trends based on hospital characteristics such as teaching status produces largely similar results. See more discussion in Section V.C, where we address endogeneity concerns. 15 These interactions are akin to including all lower-level interactions in a model with a three-way interaction, since EMR ht × Simple iht can be thought of as an interaction between a dummy for hospitals that ever adopts, a dummy for being in the post-adoption period, and the simple case dummy.
errors are clustered at the hospital level. 16 We provide separate analyses for CPOE and PD. As discussed below, the results of the effect of each application do not change if we analyze both EMRs jointly within the same regression.
We also extend our baseline model in a number of ways. First, we estimate event studies that trace the effect of EMR adoption before and after the adoption date. For this analysis, we replace the EMR dummy with binary variables indicating 3 or more years prior to adoption through 2 or more years after adoption. These additional binary variables allow for two assessments: (1) whether the impact of adoption varies with the time since adoption and (2) whether adopting hospitals have differing pre-adoption patient safety trends. In addition, we further explore an extended model that allows for an additional interaction between age and level of complexity to test whether the effect of EMRs differs by complexity within age groups.
V. Results
A. M A I N R E S U LT S
We first report our main results for CPOE in panel a of Table 3. Note that for ease of presentation, we multiply all coefficients and standard errors by 100. We find an overall negative but statistically insignificant effect of CPOE on the probability of experiencing an adverse event. Allowing for heterogeneous effects by patient age (column 1), we find that CPOE has a larger effect on nonelderly patients, suggesting that nonelderly patients are likely to benefit more from CPOE adoption, though the differences are not statistically significant. We observe starker contrasts when examining heterogeneous effects along other dimensions. We find that complex cases are not affected by CPOE; however, simple cases do experience large decreases in PSI occurrences. All interaction effects are negative, large in magnitude, and statistically significant, and F-tests reject the hypothesis that the overall effects for simple patients (main effects of CPOE plus interaction effects) are equal to zero at the 10 percent level for patients with few comorbidities and common DRGs and the 5 percent level for low-mortality risk and low-severity patients.
To be more specific, the adoption of CPOE is associated with an 11 percent ((−0.002 − 0.145)/1.34) drop in the probability of experiencing at least one postoperative adverse event for cases with no more than one comorbidity. We find no significant effect of CPOE on patients with less common DRGs; however, patients that are diagnosed with more common DRGs experience a 17 percent ((−0.047 − 0.100)/0.86) decrease in the probability of an adverse event with the adoption of CPOE. Similarly, we find a decreased rate of adverse events for patients with low mortality risk and low severity. 17 16 Weights are provided in the NIS data and are intended to produce nationally representative estimates, accounting for the sampling frame. 17 The percentage declines for these last two measures are 36 percent and 110 percent, respectively. We acknowledge that these percentage figures are high, and likely because these two events have particularly low means and we are using a linear probability model (which does not force probabilities to be above zero). We have attempted to run these two models in particular using a logit framework; however, they do not converge because of the very large number of fixed effects. Nevertheless, we note that these results, while TA B L E 3 . Effect of CPOE and PD on patient safety We have also estimated parameters for each of the four postoperative PSIs separately. These results are presented in Online Appendix Table 3 , where we find that the results for PSI 9 (hemorrhage or hematoma) and PSI 12 (pulmonary embolism or deep vein thrombosis) mirror our main findings. Results for PSI 11 (respiratory failure) have similar signs to our main results for most measures of case type, although the interaction terms are not statistically significant. The coefficients for the effect of CPOE on PSI 10 (physiological and metabolic derangement) are very small and not statistically significant. Taken together, these results suggest that our main estimates are driven by three of the four target PSIs considered in the aggregate measure.
quantitatively high in percentage terms, qualitatively line up with our results for the other higher-probability events we analyze.
The pattern of estimates observed in Table 3 suggests the importance of allowing for heterogeneity when examining the effect of CPOE adoption. Since these measures of case complexity provide variation along different dimensions, finding qualitatively consistent results among them also suggests that CPOE is more likely to improve patient outcomes for less complex cases.
To get a sense of how these improvements in PSIs translate to reduction in health-care costs, we conduct a back-of-envelope calculation using data from Zhan and Miller (2003) . For example, Zhan and Miller (2003) find that patients that have experienced postoperative respiratory failure are associated with an excess charge of $74,052 in 2014 dollars. They also provide the amount of excess charge for the other three PSIs used in our study. Since we focus on the aggregate PSI, we calculate the average excess charge across the four PSIs, which amounts to $52,409 in 2014 dollars. Zhan and Miller (2003) also find that these PSIs increase hospital stays by 6.81 days on average. According to the NIS 2010 data, a total of about 8.1 million patients nationally were at potential risk of experiencing any of the four postoperative adverse events. Depending on the definition of complexity, 3.89 million, 2.43 million, 4.94 million, and 2.84 million have few comorbidities, common DRG, low-mortality risk, and low severity, respectively.
Our results suggest that CPOE decreases the probability of such adverse events by 0.147 percentage points for patients with few comorbidities (column 2 of Table 3 ), translating to 5,718 prevented adverse events per year based on the number of few-comorbidity patients in the 2010 NIS. This amounts to a total of more than $300 million in hospital charges (or 38,942 inpatient days) for those affected simple cases in 2010. Depending on the model specification that we use, these figures range from savings of $187 million (or 24,326 inpatient days) for common-DRG cases to about $500 million (or 64,928 inpatient days) for low-mortality cases. These calculations suggest that CPOE is associated with a large decrease in hospital charges and inpatient lengths of stay. Note that since our main outcome variables are relevant for a subgroup of the patient population, those numbers represent part of the potential savings associated with EMRs.
We report the same set of results for PD in panel b of Table 3 . We find much less pronounced effects for PD, although the pattern of heterogeneous effects is similar to the findings for CPOE. PD does not statistically significantly impact the occurrence of adverse events for any of our subgroups. In results presented in Online Appendix Table 4 , we also find no impact of PD on any of the individual PSIs.
It is important to note that these results are almost identical if we combine CPOE and PD in the same regression. We also find consistent results if we create a composite measure for CPOE and PD adoption. These results are reported in Online Appendix Table 5. 18 For the remainder of the paper, we focus our analysis on CPOE, since it is the EMR, of the two, that appears to display a notable impact on PSIs.
B. T I M I N G O F E F F E C T
In this section we present event study estimates that illustrate PSI trends prior to and after EMR adoption. These estimates provide a test of our key identifying assumption that adopting hospitals do not have differential PSI trends prior to EMR adoption and shed light on whether EMR effects occur immediately or with a time lag. The adoption of a new EMR system may not immediately improve health outcomes. Health-care providers, such as physicians, nurses, and other staff, must be trained to use new systems. It may take additional time for providers to learn how to use the new systems to optimally impact patient health. 19 In this sense, we might see some delay in observing quality improvement. On the other hand, hospitals might have taken these delays into consideration when adopting an EMR. For example, employees might have been trained so that they can take advantage of the EMRs once these applications are installed and put to use.
Examining the timing of effect also mitigates a limitation of our data. Because the NIS is not a true panel, our baseline model treats hospitals that have adopted EMRs between observation years the same, regardless of which year they actually adopted the technology. By utilizing the HIMSS data to calculate the number of years an application has been installed, we can more precisely differentiate the relationship between actual adoption year and changes in patient safety.
For these event study regressions, we define the base time period as three or more years prior to adoption. We then include binary variables for two years prior to adoption, one year prior to adoption, the adoption year (year 0), one year post adoption, and two or more years post adoption. Each of these timing binary variables is also interacted with the dummy for being a simple case. For hospitals that never adopt during our time period, we set each of these binary variables to zero. For hospitals that have adopted at the beginning of our study period, for which we cannot identify the exact adoption year, we also set these binary variables equal to zero. We include never adopter and early adopter binary variables interacted with the simple case dummy, with the main effects of these indicators being absorbed by hospital fixed effects. As in our main specification, the adoption coefficients are only identified from those that adopt during our sample, but early and never adopters contribute to identification of the overall PSI time trend. These regressions control for hospital fixed effects, year fixed effects, and the same set of patient-level controls as our main specification.
Results from these specifications for CPOE are displayed in Figure 2 separately for each categorization of case complexity. The coefficients on each of the CPOE adoption time dummies, which represent changes in the aggregate PSI among complex patients relative to three years prior to adoption, are plotted in black along with their 95% confidence intervals. Changes in PSI prevalence for simple cases, which are derived by adding the main CPOE adoption time dummies plus the corresponding simple case interactions, are plotted in gray with their 95% confidence intervals.
Regardless of the definition of case type, we find no statistically significant changes in PSIs during the pre-adoption period for either complex or simple cases. This finding Information Technology and Patient Health // f re e d m a n et a l .
F I G U R E 2 . Event study estimates of CPOE adoption
Notes: These figures plot coefficients and 95 percent confidence intervals of event study estimates. These estimates trace aggregate PSI trends in PD-adopting hospitals separately for complex and simple cases. Zero corresponds to the adoption year, and all coefficients are relative to three or more years prior to the adoption year. Each figure corresponds to a separate regression. Coefficients and standard errors are multiplied by 100 to represent percentage point effects.
provides evidence that there are no differential trends in PSI prevalence between adopting and nonadopting hospitals in the years prior to the adoption actually occurring, and it provides strong support for our identification strategy. We present further tests of the identifying assumptions in the next section.
Turning to post-adoption effects, we find decreases in PSIs for simple cases after adoption similar to our main specification. However, these event study estimates suggest that the effects are small and not statistically significant in the adoption year, become larger and statistically significant the first year after adoption, and persist into the future. 20 For complex cases, we do find some evidence that CPOE decreases PSIs with a lag, although these effects are less precise, smaller than the effects for simple cases, and less robust to the definition of case complexity. We include similar figures for PD adoption in Online 20 It is notable that the timing of our results is faster than that of the cost savings found by Dranove et al. (2014) -one year versus three years post adoption. However, as they note in their event study results, shortrun cost increases in non-IT-intensive locations for advanced technologies (like CPOE and PD) materialize after just one year, suggesting that the technology is being used, but perhaps not efficiently. Hence, the combination of our findings suggests that adoption can be effective after one year (at least with regard to some PSIs) but may not be efficient that quickly.
Appendix Figure 1 . For PD we find flat pre-and post-adoption trends for both complex and simple patients, consistent with our main findings of no impact of PD adoption on patient safety.
C. A D D I T I O N A L E N D O G E N E I T Y C O N C E R N S
In this section, we further discuss and address potential endogeneity issues resulting from unobserved heterogeneity between adopting and nonadopting hospitals. We then explore whether patient composition changes following the adoption of EMRs, which might also cause bias in our estimation.
The fact that hospitals actively decide to adopt CPOE or any type of EMR applications poses concerns about potential bias. In our main specification, we use hospital fixed effects to account for the fact that adopting and nonadopting hospitals may differ in terms of baseline characteristics. Therefore, our key identifying assumption is that hospitals that adopt during our sample period do not exhibit differential trends in unobserved factors that might impact changes in PSI prevalence over time. However, there might be cases in which our assumption is not valid. For example, adopting hospitals might have been simultaneously implementing other quality initiatives to improve quality of care. If this is the case, our identification would be contaminated, as we could not differentiate whether the estimated improvement in patient outcomes is driven by CPOE or by other quality initiatives.
To address these endogeneity concerns, we adopt two strategies. First, it is the case that adopting hospitals differ from nonadopting hospitals along important observable dimensions such as ownership type, size, and teaching status. While our hospital fixed effects take into account any time-invariant differences between these types of hospitals, these hospitals might follow differing trends over time in both patient safety and EMR adoption. Our event study estimates suggest that adopting hospitals were not following differential trends prior to adoption, but here we further take into account potential unobserved heterogeneity correlated with hospital characteristics by expanding our baseline model to allow for differential trends based on teaching hospital status, ownership, and hospital size, and we find largely similar results. Our main findings are also robust to the inclusion of state-year fixed effects. 21 Second, we run our model on a set of PSIs that are not likely to be affected by EMRs because they are mostly the result of physician skills or physical accidents. For this set of PSIs, we should not expect to find any significant effect for EMRs unless our results are driven by other quality initiatives that have been implemented simultaneously with EMR adoption. These results are reported in Table 4 for PSI 6 (iatrogenic pneumothorax), PSI 8 (postoperative hip fracture), and PSI 15 (accidental puncture or laceration). For this test we present results individually for each placebo PSI to ensure that none of the three are impacted by EMR adoption.
21 These results are available in Online Appendix Table 6 . This table also includes estimates that exclude health-related control variables. Some of these controls can be in part determined by hospital procedure choice and therefore as a result of interventions to treat PSIs. The pattern of results without these controls is very similar to our main results. The counterpart results for PD are available in Online Appendix For each of these PSIs, we find very small and not statistically significant effects of CPOE, regardless of patient type. While some of the interaction terms are statistically significant, the overall effect of CPOE on each PSI for the simple groups is not statistically significant in all cases except one. It is not likely that quality initiatives would work exactly like EMRs (namely being related to our affected PSIs and not related to our unaffected PSIs). Passing these falsification tests suggests that our results are not likely driven by other quality initiatives implemented in the adopting hospitals. Note that for this falsification test, the sample is restricted to the population at potential risk for the aggregate PSI (i.e., those at risk for at least one of PSIs 9 through 12), so that these results are directly comparable to our main findings. Expanding the sample to all patients at risk for these placebo PSIs leads to very similar results. One remaining concern is that the adoption of EMRs might be related to changes in patient composition. For example, EMR adoption may cause a different set of patients to be attracted to the adopting hospital. In addition, our results would be erroneous if EMR adoption affects the margin of patients assigned to high or low levels of complexity due to changes in coding. To address these issues, we specifically explore whether patient composition changes after EMR adoption. We proceed by aggregating our data to the hospitalyear level by averaging measures of patient composition, such as age, race, insurance status, and indicators for case complexity. We then regress these measures on the adoption of CPOE and PD, controlling for time and hospital fixed effects. The results are reported in Table 5 , where all of the coefficients are small and not statistically significant. We also find no evidence that EMR adoption is associated with changes in our measures of complexity.
TA B L E 5 . Effect of EMR adoption on patient composition
Overall, we find there are no systematic changes in patient observed characteristics and patient case complexity coinciding with EMR adoption, which reassures us of the validity of our identification assumption.
In addition to exploring differential effects of CPOE along various metrics of patient complexity, we also estimate an extended model to allow these effects to vary by age group (elderly versus nonelderly) and case complexity. These results are reported in Online Appendix Table 10 . The first column replicates previous results of the heterogeneous effect by age group. In column 2, we also include an interaction between CPOE and a dummy for few comorbidities, and a three-way interaction between CPOE, nonelderly, and few comorbidities. The results suggest that the largest decrease in occurrence of adverse events is realized for nonelderly, simple cases. In the remaining columns, we also explore commonality of DRG (column 3), mortality risk (column 4), and severity (column 5). We find consistent results that CPOE has the largest impact for nonelderly, simple patients. In addition, we also see some improvement in patient outcomes for elderly but simple cases.
E. T W O A LT E R N AT I V E O U T C O M E S
In addition to PSIs, we also present results using two alternative outcomes: inpatient mortality and length of stay. Mortality has been commonly used in the existing studies examining the impact of EMRs. Previously, we argued one concern about using mortality is that it is an extreme outcome, so it might fail to capture improvement in patient outcomes that are not directly tied to patient death. To compare our findings with the previous literature, we provide additional analyses using inpatient mortality as the outcome. In our data, we observe when a patient dies during their hospital stay; however, the results have to be taken cautiously as inpatient mortality does not capture death that occurs during a readmission or outside of the hospital.
The results for inpatient mortality are reported in Table 6 . Consistent with previous findings, we find no effect of CPOE on inpatient mortality, regardless of patient characteristics. 23 In results that we do not report here, we also find no effect of PD on inpatient mortality. 22 We also verify that there are no changes in patient composition within simple and complex patient groups in Online Appendix Tables 8 and 9 . The only exception is statistically significant effects on the number of patients within each group. We believe this to not be a major issue, since the results presented in Table  5 show no statistically significant impact of EMR adoption on the fraction of patients in the less complex groups. These two findings in tandem indicate that the significant change in the number of patients is primarily driven by observations with a large base of patients-observations for which a small relative effect (i.e., a small change in proportion) would still be able to generate a nontrivial level effect (i.e., a significant change in patient count). 23 The mean mortality rate is 0.017 with a standard deviation of 0.128 in the data. We also estimate an extended model to allow three-way interaction terms for CPOE, nonelderly, and dummies for complexity. We find consistent results that there is no effect of CPOE on patient mortality. The other outcome we examine is patient length of stay (logarithm), and the results are also reported in Table 6 , multiplied by 100 to represent percentage effects. 24 Interestingly, we find a large decrease in length of stay (LOS) for simple cases in three of our five specifications, consistent with our main findings that CPOE lowers the probability of adverse events, which themselves are likely to increase length of stay for those patients. For example, we find that CPOE lowers patient LOS by 0.91 percent for low-mortality-risk patients and 1.66 percent for low-severity patients. We do not find statistically significant effects for complex cases. Finding a negative effect for LOS and no effect for inpatient mortality among the same set of patients highlights the importance of using a less extreme outcome measure in capturing improvement in quality of care for simple cases.
TA B L E 6 . Alternative outcome measures
(0) (1)(2)
VI. Discussion and Conclusion
By combining the Healthcare Information and Management Systems Society Analytics Database with the National Inpatient Sample, we test how adoption of advanced electronic medical records (CPOE and PD) affects the incidence of patient safety indicators, and whether this effect differs across case complexity. We find that CPOE leads to improved patient outcomes for less complex cases. This finding is robust to a variety of measures of case complexity. We also find some evidence that CPOE reduces adverse events for some complex patients. These latter results are not statistically significant overall, but appear for some measures of complex cases with lagged effects. We find no evidence that PD impacts patient safety.
It remains an interesting question why predominantly less complex patients are drawing PSI benefits from CPOE. We postulate that the reason may have to do with decision support, because (1) less-complex cases are relatively more impacted by decision support, (2) PSIs likely measure quality of care for less-complex cases better (versus, e.g., mortality) and are likely more sensitive to decision support, and (3) CPOE has relatively more decision support capability (relative to PD). We discuss each component in turn below.
First, it is likely that decision support, at the current level of sophistication, only works to improve quality of care for less complex cases. The informatics literature suggests that treatment guidelines, protocols, and reminders are currently less beneficial when providers must care for complex patients with multiple interacting conditions and other case complexities. For example, Musen, Shahar, and Shortliffe (2006) argue that rule-based decision making that can be aided by decision support systems is most effective when a simple rule is available for a well-defined problem. The field of bioinformatics continues to struggle with the design and implementation of decision support systems for patients with multiple comorbidities. Therapeutic plans and clinical guidelines are typically disease specific without clear recommendations for handling comorbidities (Jafarpour and Abidi 2013) . There is concern that some decision support systems may in fact present harmful advice if they do not properly account for comorbidities (Fraccaro et al. 2015) . While the field of informatics is making progress in developing methods for merging clinical guidelines in decision support systems (Jafarpour and Abidi 2013) , this area has been identified as a "grand challenge" in the field of decision support (Sittig et al. 2008) and remains under-investigated (Fraccaro et al. 2015) .
Second, it could be that the patient safety indicator outcome variables that we use better capture quality of care interventions for less complex cases and are more sensitive to decision support. For example, our outcome variables may not be sensitive to care coordination, which we might expect to have a larger impact in more complex cases. While much of the prior literature focuses on patient mortality and finds no positive returns for EMR technologies, McCullough, Parente, and Town (2013) find evidence that EMRs improve mortality for the highest-severity Medicare patients, particularly those needing multiple coordinated providers or synthesis of large amounts of clinical information. Hence, it could be possible to find improvement for complex patients when examining measures other than PSIs, which may have a more direct link to outcomes for more complex cases and/or are more sensitive to care coordination, as may be the case with patient mortality.
Third, as indicated in Section II.C, there is reason to believe CPOE and PD may have differing impacts on health outcomes, since the former has more capability toward clinical decision support and the latter toward care coordination. The fact that we find consistent results that CPOE significantly reduces adverse events for less complex cases in the postsurgical setting provides suggestive evidence that the decision support mechanism is improving quality of care. While McCullough, Parente, and Town (2013) do not find empirical evidence for the prediction that decision support applications have meaningful health effects in less complex cases, our context leads to different results likely because our analysis uses a more diverse patient population and an outcome measure that might better capture quality differences for less complex patients. Consequently, our finding complements the findings of McCullough, Parente, and Town (2013) regarding care coordination mechanisms. Further, it is also consistent with a previous study by Javitt, Rebitzer, and Reisman (2008) that finds improvements in quality of care from decision support in an HMO population of patients all less than 65 years of age.
Our findings have important implications concerning the impact of EMR adoption on health outcomes. First, taken together with studies like McCullough, Parente, and Town (2013), our findings suggest that different mechanisms can improve care along different metrics of quality for different patient populations. They also suggest that it may be difficult to draw conclusions about the effectiveness of EMRs from overall estimates of changes in extreme outcomes like mortality. Second, the fact that we do not find evidence of care coordination playing a large role for the broad patient population in our study suggests that the impact of care coordination via EMRs might be currently limited to a relatively small group of patients. Such lack of evidence also suggests that further improvement in the interoperability of EMR systems and improved ability to take advantage of large amounts of data provided by EMR systems are necessary to reap their full benefits. Note that one caveat of this finding is that the outcome measures we use might fail to capture improvements in patient outcomes through care coordination. Finer data might also be needed to identify the set of patients that are more likely to be affected through this mechanism.
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